Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-05-27

Differential diagnosis of infecious lung diseases

Objective

Infectious pulmonary diseases form a serious threat to human warfare. Pneumonia continues to be a major health problem despite the availability of potent ant microbial drugs. Bacterial pulmonary diseases are often caused by Streptococcus pneumonia, Mycoplasma pneumonia, Chlamydeous pneumonia, Legion Ella pneumophila, Staphylococcus aurous, and Mycobacterium tuberculosis. Compromised-compromised hosts, such as HIV patients, form a special target group. Diagnostic test are available for these pulmonary diseases but there is still an urgent need for more accurate and rapid diagnoses. This project will focus on developing a simplified and user-friendly test combining detection of pathogen components (nucleic acids/proteins) and host components (antibodies) with a high diagnostic reliability. In its final format the test allows differential diagnosis of infectious pulmonary diseases. The new and innovative part of the project is that the resulting differential test format will have an appreciable added reliability, as
(I) the combined pathogen and host response test results will increase the sensitivity of the method, and
(ii) the combined testing for the major differential diagnostic causes of lung disease will increase the specificity. The principle of

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

Data not available

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

EAW - Exploratory awards

Coordinator

KREATECH BIOTECHNOLOGY BV
EU contribution
No data
Address
3,Vlierweg 20
1032 LG AMSTERDAM
Netherlands

See on map

Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (1)

My booklet 0 0